Squitieri & Fearon, LLP is investigating possible claims for participants in the Aetna 401(k) Plan who received CVS stock when CVS acquired Aetna in November 2018.
We are investigating claims for participants in the Aetna 401(k) Plan who had invested in Aetna stock through the plan and whose Aetna stock was converted into CVS stock when CVS acquired Aetna. (NYSE:AET and NYSE:CVS) We are investigating whether the CVS stock was artificially inflated at the time, meaning that the Aetna employees received less than they should have for their Aetna shares.
If you or someone you know participated in the Aetna 401(k) Plan and held Aetna stock in that plan that was converted into CVS stock, and you would like to learn more about our investigation, please fill out our online form, or contact Stephen Fearon at stephen@sfclasslaw.com or by phone at (212) 421-6492. You can also complete the following form, and someone from the firm will contact you.